NewsRoom Articles - Page 179 of 541

MondaySep 13, 2021 3:02 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Impressive Blood Pressure Reduction in Hypertension Clinical Trials

Lexaria Bioscience has developed a patented technology that improves the bioavailability of pharmaceuticals and therapeutics in part by bypassing first-pass-liver processing Lexaria’s patented DehydraTECH (TM) technology is undergoing human clinical trials this year to determine its effectiveness in making cannabidiol (“CBD”) effective as a means of reducing blood pressure for high blood pressure patients The initial results of the first human clinical study showed the DehydraTECH-CBD compound was well tolerated by patients without troubling side effects and that the compound outperformed generic CBD controls Just-released initial (partial) results regarding the compound’s second human clinical trial show that a three-dose regimen…

MondaySep 13, 2021 12:34 pm

Flora Growth Corp. (NASDAQ: FLGC) Expands Across International Borders into Europe and Asia

Flora Growth business divisions include pharmaceuticals, cosmetics, hemp textiles, and food & beverage sectors Flora Lab now has three GMP certifications – one each for cosmetics, phytotherapeutic products, and dietary supplements Flora Growth operates internationally but has its cultivation and processing operations based in Colombia – with one of the largest outdoor cultivation facilities in the world, aiming to produce medical-grade cannabis flower and derivative products at below-market pricing Proposed acquisitions of Vessel Brand and Koch & Gsell, as well as investment into Hoshi International, will help expand the business across international borders and into the US, Europe, and Asia…

MondaySep 13, 2021 4:20 am

420 with CNW — Could Cannabis Drinks Be Better for Your Health?

As cannabis and cannabis products become more accessible thanks to a wave of drug reform that has swept through several territories, people are increasingly using marijuana as an alternative to other products. Due to recent advances in cannabis technology, specifically nano-emulsification, the market has seen an uptick in the supply of smooth, high-quality, cannabis-infused drinks. Plenty of people are now using cannabis-infused beverages as an alternative to alcohol, with many of them preferring a calm relaxing drink that won’t leave them feeling hangover the next day. Dubbed “California sober,” exchanging alcoholic beverages for cannabis drinks is gaining popularity. Melissa Egan,…

FridaySep 10, 2021 4:20 pm

420 with CNW — The Difference Between CBD Oil, Cannabis Oil

The popularity of CBD oil has grown in the health and wellness space, with anecdotal evidence suggesting that it can help manage depression, anxiety, stress and pain. Cannabidiol, or CBD, oil and cannabis oil have also been advertised as natural alternatives to standard prescription medications, which many believe are one and the same. While both oils are derivatives of the cannabis plant, they are inherently different. We look at some of these differences below. What is cannabis oil? Cannabis oil contains THC, which is the mind-altering compound that causes an individual to get high. The sale, consumption and possession of…

FridaySep 10, 2021 9:15 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Marks Impressive Performance for Q2 2021

$58.5 million in Adjusted Sales for first six months of 2021 The company also reported repaying approximately $18 million of debt and restructuring over $20 million into a long-term debt Q2 also marked RWB’s acquisition of Acreage Florida, as well as an operational 45,000 SF greenhouse within the state, which it projects, will begin harvesting in Q4 2021 RWB’s CEO expressed his optimism about the company’s performance in the Q3 and the second half of the year, given the strides made and the momentum realized in Q2 On August 30, Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) released…

FridaySep 10, 2021 9:00 am

RYAH Group Inc. (CSE: RYAH) Publishes Report Outlining Cannabis Treatments for Conditions Associated with HIV and AIDS

RYAH releases report outlining ways cannabis is being used to treat conditions associated with HIV and AIDS Report data compiled by RYAH Data Ecosystem between January 1, 2018, and August 26, 2021 Data includes specific HIV and AIDS conditions, details cannabis strains used by patients Three-part RYAH Data Ecosystem includes volume control and management devices, QR tracking to identify product formulations and parameters, mobile apps to manage information and provide feedback With a mission to advance remote-health solutions and analytics-based patient treatments across the world, RYAH Group (CSE: RYAH) (formerly RYAH Medtech) is the leader in volume control and management…

FridaySep 10, 2021 4:20 am

420 with CNW — Why Careful Cannabis Preparation Is Crucial to High-Quality Extracts

Just a couple of years into America’s state-legal cannabis industry, extracts have eclipsed cannabis flower to become the most popular cannabis product. Last year, marijuana concentrate sales increased by 40% and accounted for a large percentage of marijuana sales. People are looking for safer, more discreet ways to consume cannabis, and consequently, smoking cannabis flower and vaping have been edged out by cannabis extracts. However, marijuana extracts are quite complex to produce, requiring precise, expert care from the time the cannabis plants are in the ground until they reach the factory. In the early days of cannabis extraction, most cannabis…

ThursdaySep 09, 2021 4:20 pm

420 with CNW — Cannabis Trade Groups Submit Formal Comments on Sen. Schumer’s Federal Legalization Measure

Various national cannabis activist groups and trade organizations have submitted formal comments on the draft of the latest federal initiative on cannabis reform, many of which emphasize the need for interstate commerce and lower taxes. The written comments, which were due to the U.S. Senate last week, include more than 150 pages of feedback on the comprehensive reform measure that’s being spearheaded by Democratic Senators Ron Wyden and Cory Booker along with Senate Majority Leader Chuck Schumer. The bill, dubbed the Cannabis Administration and Opportunity Act, would legalize cannabis on a federal basis by allowing states to continue deciding whether…

ThursdaySep 09, 2021 1:28 pm

Flora Growth Corp. (NASDAQ: FLGC) Inks €2M Investment in Hoshi As Part of its European Expansion Plan

Flora closed a €2 million investment in Hoshi International Inc., fulfilling the earlier-announced LOI back in June 2021 This move is set to capitalize on Hoshi’s strong European presence, its technical know-how along with its understanding of the European market Hoshi acknowledged the investment with the announcement that it would work together with Flora to bring to market finished product formats from Flora’s brand portfolio Flora referred to this investment as the first of many steps by the company to advance its plans to launch products across the world On August 24, 2021, Flora Growth (NASDAQ: FLGC) announced closing a…

ThursdaySep 09, 2021 1:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) to Address Advances in its Bioavailability Technology DehydraTECH(TM) at Wainwright Life Sciences Conference

Drug delivery technology innovator Lexaria Bioscience is celebrating the positive outcomes of clinical testing of its trademarked DehydraTECH platform for reducing the blood stream delivery time of anti-virals, NSAIDS and potential hypertension treatments Lexaria will participate in H.C. Wainwright’s annual Global Investor Conference this month to help bring further attention to its successes The DehydraTECH technology enhances the delivery of pharmaceuticals that can be administered orally, and testing has shown no adverse chemical compounds have been created in the process The COVID-19 pandemic has raised the profile of the anti-viral medication market, enhancing the opportunities for Lexaria’s revenue stream As…

News and publishing service for cannabis related companies

Contact us: 303.498.7722